Physician profile
Parul Patel
NPI 1710988415
$5,377.89
in general payments reported to CMS, 2019-2025
35 companies · $185 in 2025
The $185 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $807 · 2020: $922 · 2021: $1,103 · 2022: $1,116 · 2023: $738 · 2024: $508 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,429.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $1,550.35 | 2019-2025 | Breztri, Farxiga |
| Abbvie INC. | $573.04 | 2019-2024 | |
| Lilly USA, LLC | $568.89 | 2019-2024 | Mounjaro, Jardiance, Emgality |
| Amgen INC. | $451.95 | 2019-2024 | Repatha, Otezla, Evenity |
| Novo Nordisk INC | $447.90 | 2019-2024 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $265.87 | 2019-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $240.34 | 2020-2024 | Trintellix |
| Glaxosmithkline, LLC. | $176.83 | 2019-2023 | Arexvy, Shingrix |
| Allergan, INC. | $130.59 | 2019-2020 | |
| Abbott Laboratories | $127.52 | 2022-2025 | Freestyle Libre 3 |
| Genentech USA, INC. | $90.39 | 2019-2021 | |
| Astellas Pharma US INC | $79.59 | 2020-2024 | Veozah |
| Amarin Pharma, INC. | $74.79 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $65.15 | 2019-2021 | |
| Organogenesis INC. | $60.73 | 2024-2025 | Affinity |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $60.28 | 2022-2023 | Azstarys |
| Jazz Pharmaceuticals INC. | $42.75 | 2022 | |
| Dexcom, INC. | $34.99 | 2022-2023 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $33.84 | 2023 | |
| Currax Pharmaceuticals LLC | $27.77 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $26.47 | 2022 | Xyosted, Tlando |
| Exact Sciences Corporation | $25.57 | 2024 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $23.45 | 2020 | |
| Eisai INC. | $21.19 | 2020 | |
| Halozyme INC | $19.95 | 2023 | |
| Idorsia Pharmaceuticals US INC | $19.43 | 2023 | Quviviq |
| Esperion Therapeutics, INC. | $18.64 | 2024 | Nexletol |
| Ironshore Pharmaceuticals INC. | $17.73 | 2019 | |
| Adlon Therapeutics L.P. | $17.62 | 2019 | |
| Neos Therapeutics, Lp | $17.41 | 2019 | |
| Axsome Therapeutics, INC. | $16.11 | 2024 | Auvelity |
| Biohaven Pharmaceuticals, INC. | $13.62 | 2021 | |
| Avanir Pharmaceuticals, INC. | $13.55 | 2019 | |
| Molnlycke Health Care US, LLC | $12.76 | 2025 | Exufiber, Mepilex Transfer Ag, Tubigrip |
| Shire North American Group INC | $10.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parul Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.